Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Director/PDMR Shareholding

11 Aug 2016 15:01

RNS Number : 9714G
Croda International PLC
11 August 2016
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1) Stephen Edward Foots

2) Dr Keith Layden

3) Jeremy Kim Maiden

4) Stuart Arnott

5) Mrs Sandra Elaine Breene

6) Thomas Michael Brophy

7) Dr Nicholas Ian Challoner

8) Anthony Damien Fitzpatrick

9) Maarten Willem Heijbroek

10) Graham Lloyd Myers

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1) Executive Director (PDMR)

2) Executive Director (PDMR)

3) Executive Director (PDMR)

4) Member of Executive Committee (PDMR)

5) Member of Executive Committee (PDMR)

6) Company Secretary (PDMR)

7) Member of Executive Committee (PDMR)

8) Member of Executive Committee (PDMR)

9) Member of Executive Committee (PDMR)

10) Member of Executive Committee (PDMR)

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

 

Croda International Plc

b)

 

LEI

 

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 10.357143p each

 

ISIN: GB00BYZWX769

 

b)

 

Nature of the transaction

 

 

 

Purchase of shares under the Company's Share Incentive Plan by the SIP Trustee (Capita IRG Trustees Ltd) - partnership shares purchased on behalf of PDMRs as detailed in c) and matching shares awarded to PDMRs as detailed in c).

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

1) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

2) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

3) 3370p

0p

5 (Partnership shares)

5 (Matching Shares)

4) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

5) 3248p

0p

4 (Partnership shares)

4 (Matching Shares)

6) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

7) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

8) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

9) 3370p

0p

5 (Partnership shares)

5 (Matching Shares)

10) 3370p

0p

4 (Partnership shares)

4 (Matching Shares)

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

Aggregated volume

Aggregated Price

1)

8

1685p per share

2)

8

1685p per share

3)

10

1685p per share

4)

8

1685p per share

5)

8

1685p per share

6)

8

1685p per share

7)

8

1685p per share

8)

8

1685p per share

9)

10

1685p per share

10)

8

1685p per share

 

 

e)

 

Date of the transaction

 

 

2016-08-10

f)

 

Place of the transaction

 

 

XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZFLFFQVFBBBB
Date   Source Headline
11th Jan 20233:45 pmRNSDirector/PDMR Shareholding
13th Dec 20223:04 pmRNSDirector/PDMR Shareholding
6th Dec 202212:36 pmRNSDirector/PDMR Shareholding
14th Nov 20223:33 pmRNSHolding(s) in Company
11th Nov 20222:04 pmRNSDirector/PDMR Shareholding
11th Nov 202210:37 amRNSDirector/PDMR Shareholding
11th Nov 202210:33 amRNSDirector/PDMR Shareholding
8th Nov 202211:23 amRNSDirector/PDMR Shareholding
7th Nov 20226:11 pmRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSJez Maiden to retire as Group Finance Director
3rd Nov 20225:53 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:50 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:49 pmRNSDirector/PDMR Shareholding
11th Oct 20221:37 pmRNSDirector/PDMR Shareholding
7th Oct 20228:37 amRNSDirector/PDMR Shareholding
7th Oct 20227:59 amRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSInvestor seminar
5th Oct 20224:42 pmRNSDirector/PDMR Shareholding
20th Sep 20229:01 amRNSDirector/PDMR Shareholding
13th Sep 20221:47 pmRNSDirector/PDMR Shareholding
11th Aug 20222:39 pmRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSResults for the six months ended 30 June 2022
22nd Jul 20224:50 pmRNSDirectorate Change
12th Jul 20223:08 pmRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSCompleted divestment
30th Jun 202212:15 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSUS Government to support lipid systems expansion
22nd Jun 20229:07 amRNSHolding(s) in Company
17th Jun 20229:46 amRNSHolding(s) in Company
13th Jun 20222:52 pmRNSDirector/PDMR Shareholding
8th Jun 202211:53 amRNSDirector/PDMR Shareholding
7th Jun 20225:23 pmRNSTransaction in Own Shares
7th Jun 20224:08 pmRNSDirector/PDMR Shareholding
7th Jun 20223:27 pmRNSHolding(s) in Company
27th May 202210:48 amRNSHolding(s) in Company
26th May 20227:02 amRNSDirector Declaration
23rd May 20222:34 pmRNSResult of AGM
20th May 20227:21 amRNSAGM trading update
19th May 20223:09 pmRNSDirector/PDMR Shareholding
19th May 20222:17 pmRNSHolding(s) in Company
11th May 20222:15 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSSite visit and investor presentation
3rd May 202210:21 amRNSDirector/PDMR Shareholding
13th Apr 20229:48 amRNSDirector/PDMR Shareholding
7th Apr 20226:15 pmRNSDirector/PDMR Shareholding
31st Mar 20223:12 pmRNSUK Government to support lipid systems expansion
29th Mar 20227:00 amRNSInvestor seminar
22nd Mar 20226:14 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.